Skip to main content

Animations

MJFF Publications

7491 - 7500 of 9030 Results
Title
Year
  • Year
  • 2016
  • 2019
  • 2017
  • 2020
  • 2015
  • 2016
  • 2021
  • 2015
  • 2015
  • 2021
  • Summary Details
    OPEN
    Title: Inflammatory profile in LRRK2-associated prodromal and clinical PD
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-016-0588-5
    Citation Count: 76
  • Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease
    2019
    Summary Details
    RESTRICTED
    Title: Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10286-019-00632-w
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Orthostatic hypotension in Parkinson disease: Impact on health care utilization
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.11.344
    Citation Count: 48
  • Summary Details
    OPEN
    Title: SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorder
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.04.005
    Citation Count: 6
  • Summary Details
    OPEN
    Title: A novel class of negative allosteric modulators of NMDA receptor function
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2015.10.046
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Predictors of time to initiation of symptomatic therapy in early Parkinson's disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.317
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Novel Thienopyrimidine-Based PET Tracers for P2Y12 Receptor Imaging in the Brain
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00641
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2015.03.008
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.09.014
    Citation Count: 109
  • Summary Details
    OPEN
    Title: Identification of LRRK2 missense variants in the accelerating medicines partnership Parkinson’s disease cohort
    Journal Name: Human Molecular Genetics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/hmg/ddab058
    Citation Count: 35
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.